Advanced Malignant Solid Neoplasm Recruiting Phase 1 / 2 Trials for Avelumab (DB11945)

IndicationStatusPhase
DBCOND0082736 (Advanced Malignant Solid Neoplasm)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03217747Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesTreatment
NCT04068194Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesTreatment